Glucagon-like peptide agonists (GLP-1) drugs were originally approved to help manage Type 2 diabetes (T2D) and are now also being prescribed and used for weight management
Gallbladder disease : Rapid weight loss increases cholelithiasis risk
Grand challenges in pharmaceutical research series: ridding the cold chain for biologics
It plays several important roles: Helping maintain healthy blood sugar levels after meals Supporting a feeling of fullness and satisfaction Regulating appetite and digestion When GLP-1 activity is healthy, it may help reduce cravings, support balanced energy, and contribute to gradual, sustainable weight management
If you're considering GLP-1 medication, talk with your weight management doctor to determine which is best for your needs
Inhibition of SGLT2 reduces sodium reabsorption in the proximal tubule and enhances Na + delivery to the macula densa, promoting finally the TGF activation with consequent afferent arteriole vasoconstriction and reduction of the single-nephron-glomerular-filtration-rate ( Figure 1 )
